Get 40% Off
These stocks are up over 10% post earnings. Did you spot the buying opportunity? Our AI did 😎Read how

Gold Up, Amid Senate Delay on U.S. Stimulus Checks Increase Vote

Published 12/29/2020, 11:41 PM
Updated 12/29/2020, 11:42 PM
© Reuters.

By Gina Lee

Investing.com – Gold was up on Wednesday morning in Asia, boosted by a weaker dollar. Investors are also digesting the news that U.S. Senate Majority Leader Mitch McConnell postponed a vote on increasing the amount of U.S. stimulus checks.

Gold futures were up 0.32% at $1,888.85 by 11:40 PM ET (4:40 AM GMT). The {{8827|dollar}, which usually moves inversely to gold, was down on Wednesday morning.

“A weaker dollar is enough to create a small upward momentum for confidence to be maintained in gold,” AirGuide director Michael Langford told CNBC.

McConnell delayed a vote on increasing the amount on the stimulus checks from $600 to $2,000 on Tuesday, after the House of Representatives and President Donald Trump both approved the increase earlier in the week.

However, Treasury Secretary Steven Mnuchin said that distribution of the approved $600 stimulus checks would begin as soon as Tuesday evening.

The Federal Reserve also extended the end date for its Main Street Lending Program by eight days to Jan. 8, in order to process a flood of applications that were submitted since Mnuchin ended the central bank's emergency credit facility in November.

All eyes are now on runoff elections in Georgia, due to take place on Jan. 5, that will determine whether the Democrats or Republicans control the Senate.

Should the elections result in victory for the Democrats, expectations of a continuous loose fiscal policy will weigh on the dollar and be bullish for precious metals, Phillip Futures senior commodities manager Avtar Sandu said in a note.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Meanwhile, COVID-19 vaccine rollouts continue globally, with the European Union set to purchase a further 100 million doses of BNT162b2, the vaccine developed by Pfizer Inc (NYSE:PFE) and BioNTech SE (F:22UAy).

The number of global COVID-19 cases continues an incessant increase. The U.S. has also reported its first case of the B177 strain of the COVID-19 virus, first seen in southeastern England in September.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.